$IRD
Opus Genetics, Inc.

2022 Q3 Form 10-Q Financial Statement

#000114036122029461 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.703M $1.776M $1.736M
YoY Change 6.77% -47.89% 2.12%
% of Gross Profit
Research & Development $2.835M $3.162M $4.772M
YoY Change -17.42% 37.05%
% of Gross Profit
Depreciation & Amortization $1.000K $1.000K $1.000K
YoY Change 0.0% 0.0% 0.0%
% of Gross Profit
Operating Expenses $4.538M $4.938M $6.508M
YoY Change -31.77% 25.49%
Operating Profit -$4.538M -$4.938M -$6.508M
YoY Change 7.23% -30.81% 25.49%
Interest Expense $0.00 $4.000K $5.000K
YoY Change
% of Operating Profit
Other Income/Expense, Net $7.000K $15.00K -$82.00K
YoY Change 250.0% 1400.0% -8300.0%
Pretax Income -$4.531M -$4.927M -$6.595M
YoY Change 7.12% -30.96% -83.1%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.531M -$4.927M -$6.595M
YoY Change 7.12% -30.96% -83.1%
Net Earnings / Revenue
Basic Earnings Per Share -$0.22 -$0.25 -$0.35
Diluted Earnings Per Share -$0.22 -$0.25 -$0.35
COMMON SHARES
Basic Shares Outstanding 20.58M 19.50M 18.89M
Diluted Shares Outstanding 20.50M 19.50M 18.89M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.96M $17.15M $19.38M
YoY Change -38.34% -29.23% 82.84%
Cash & Equivalents $13.86M $17.03M $19.25M
Short-Term Investments $101.0K $126.0K $135.0K
Other Short-Term Assets $61.00K $31.00K $1.095M
YoY Change 32.61% -96.76% 4111.54%
Inventory
Prepaid Expenses $544.0K $709.0K
Receivables
Other Receivables
Total Short-Term Assets $14.56M $17.89M $20.48M
YoY Change -37.22% -29.12% 69.04%
LONG-TERM ASSETS
Property, Plant & Equipment $7.000K $8.000K $9.000K
YoY Change -36.36% -33.33% -30.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $7.000K $8.000K $9.000K
YoY Change -36.36% -33.33% -30.77%
TOTAL ASSETS
Total Short-Term Assets $14.56M $17.89M $20.48M
Total Long-Term Assets $7.000K $8.000K $9.000K
Total Assets $14.57M $17.90M $20.49M
YoY Change -37.22% -29.12% 68.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.468M $1.886M $1.579M
YoY Change 2.37% 26.07% 11.59%
Accrued Expenses $1.223M $1.418M $1.419M
YoY Change 1.58% 17.87% 58.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $215.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.691M $3.304M $3.213M
YoY Change 2.01% 22.42% 39.09%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.691M $3.304M $3.213M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.691M $3.304M $3.213M
YoY Change 2.01% 22.42% 39.09%
SHAREHOLDERS EQUITY
Retained Earnings -$105.4M -$100.9M
YoY Change
Common Stock $2.000K $2.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.88M $14.60M $17.27M
YoY Change
Total Liabilities & Shareholders Equity $14.57M $17.90M $20.49M
YoY Change -37.22% -29.12% 68.93%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$4.531M -$4.927M -$6.595M
YoY Change 7.12% -30.96% -83.1%
Depreciation, Depletion And Amortization $1.000K $1.000K $1.000K
YoY Change 0.0% 0.0% 0.0%
Cash From Operating Activities -$4.498M -$3.809M -$6.170M
YoY Change 25.5% -12.03% 6.16%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.328M 1.588M 882.0K
YoY Change -17.0% -91.16% 8720.0%
NET CHANGE
Cash From Operating Activities -4.498M -3.809M -6.170M
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 1.328M 1.588M 882.0K
Net Change In Cash -3.170M -2.221M -5.288M
YoY Change 59.78% -116.29% -8.86%
FREE CASH FLOW
Cash From Operating Activities -$4.498M -$3.809M -$6.170M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001228627
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
17025000
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
24534000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
50000
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
709000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1243000
us-gaap Operating Lease Cost
OperatingLeaseCost
21000
us-gaap Operating Lease Cost
OperatingLeaseCost
98000
us-gaap Depreciation
Depreciation
2000
us-gaap Depreciation
Depreciation
2000
us-gaap Interest Expense
InterestExpense
9000
ocup Number Of Directors Signed Waiver Agreements
NumberOfDirectorsSignedWaiverAgreements
6
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
445000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
463000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
890000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
957000
CY2022Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
14147
CY2021Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
4923
CY2022Q2 ocup Number Of Board Members Granted Stock Awards For Services
NumberOfBoardMembersGrantedStockAwardsForServices
2
CY2021Q2 ocup Number Of Board Members Granted Stock Awards For Services
NumberOfBoardMembersGrantedStockAwardsForServices
2
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
22171
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
9397
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
27000
CY2021Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
29000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
55000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
55000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P7M
ocup Operating Leases Monthly Base Rent
OperatingLeasesMonthlyBaseRent
3000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
9000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
50000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
18000
CY2022Q2 us-gaap Interest Expense
InterestExpense
4000
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
31000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
71000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
740000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1314000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10000
CY2021Q2 us-gaap Depreciation
Depreciation
1000
CY2022Q2 us-gaap Depreciation
Depreciation
1000
CY2022Q2 ocup Accrued Research And Development Services And Supplies Current
AccruedResearchAndDevelopmentServicesAndSuppliesCurrent
945000
CY2021Q4 ocup Accrued Research And Development Services And Supplies Current
AccruedResearchAndDevelopmentServicesAndSuppliesCurrent
1081000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
330000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
488000
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
104000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
84000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
39000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
80000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1418000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1733000
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
600000
CY2022Q2 ocup Debt Instrument Number Of Installments
DebtInstrumentNumberOfInstallments
6
CY2022Q2 us-gaap Short Term Debt Percentage Bearing Fixed Interest Rate
ShortTermDebtPercentageBearingFixedInterestRate
0.055

Files In Submission

Name View Source Status
0001140361-22-029461-index-headers.html Edgar Link pending
0001140361-22-029461-index.html Edgar Link pending
0001140361-22-029461.txt Edgar Link pending
0001140361-22-029461-xbrl.zip Edgar Link pending
brhc10040525_10q.htm Edgar Link pending
brhc10040525_ex10-1.htm Edgar Link pending
brhc10040525_ex31-1.htm Edgar Link pending
brhc10040525_ex31-2.htm Edgar Link pending
brhc10040525_ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ocup-20220630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
ocup-20220630_cal.xml Edgar Link unprocessable
ocup-20220630_def.xml Edgar Link unprocessable
ocup-20220630_lab.xml Edgar Link unprocessable
ocup-20220630_pre.xml Edgar Link unprocessable
brhc10040525_10q_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable